3% diquafosol sodium eye drops in Chinese patients with dry eye: a phase IV study.

Wenying Wang,Xiaonan Sun, Jiangyue Zhao,Jilong Hao,Shaozhen Zhao,Xiaoming Yan, Ye Shen,Xiuming Jin, Yan Cheng,Linnong Wang,Jianjiang Xu,Peiquan Zhao,Hai Liu, Siming Zeng,Xu Wang,Weili Dong, Jinsong Xue,Wei Chen, Ping Guo, Li Li,Lijun Zhang,Dachuan Liu, Baihua Chen, Zhouqiao Lin,Yanjiang Fu,Lingyi Liang, Yanling Dong, Weizhong Yang,Yingping Deng,Guigang Li,Zhiqiang Pan

Frontiers in medicine（2023）

引用 0|浏览14

暂无评分

摘要

The use of 3% diquafosol sodium eye drop is effective and safe in the treatment of dry eye, with a low incidence of ADRs showing mild symptoms. This trial was registered at Chinese Clinical Trial Registry ID: ChiCTR1900021999 (Registration Date: 19/03/2019).

查看译文

关键词

dry eye, diquafosol sodium eye drops, efficacy, safety, flourescein staining

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要